Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-l)
Clinics should not be offering it as an approved treatment
doi: 10.2174/1573399812666160421121307 5 RawlaPVellipuramARBandaruSSPradeep RajJ
It produces meaningful weight loss of approximately 12.4% at the highest dose, somewhat less than injectable alternatives
Stopping any of these medications abruptly can lead to rebound hunger, blood sugar fluctuations, and weight regain
US$ 21.77
&srotate=0)
US$ 22.93
US$ 29.58
